SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JMM who wrote (5139)8/13/1998 4:03:00 PM
From: Zirdu   of 6136
 
<<It's ironic that its a disease that people want to control and have less of... but some companies have it as a growth vehicle for profits.>>

Huh?? I don't see the irony here. Don't people "want to control and have less of " ALL diseases? And doesn't EVERY drug company that makes a drug that targets any disease, see that drug "as a growth vehicle" for their company?

I'd say this system (i.e. companies with a profit motive developing drugs to combat diseases) has worked well at developing many amazing new drugs we wouldn't otherwise have. And in the long run, all you have to do is wait a few years and all these drugs will be "off patent", so any company can manufacture and sell them without royalties.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext